Elder Pharmaceuticals Ltd Half Yearly Results

Gross Sales

357.2

350.23

655.9

696.77

757.51

Excise Duty

0

0

0

0

0

Net Sales

357.2

350.23

655.9

696.77

757.51

Other Operating Income

3.85

-1.15

3.93

1.08

1.27

Other Income

15.1

386.11

10.81

17.21

13.22

Total Income

376.16

735.2

670.64

715.07

772.01

Total Expenditure

417.17

505.29

582.78

594.54

646.23

PBIDT

-41

229.89

87.83

120.51

125.76

Interest

68.23

189.47

86.16

53.56

53.45

PBDT

-109.23

40.43

1.67

66.94

72.31

Depreciation

20.25

15.82

20.29

17.7

18.3

Minority Interest Before NP

0

0

0

0

0

Tax

0.64

1.66

1.58

9.57

12.36

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-130.13

22.92

-20.19

39.65

41.63

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-130.13

22.92

-20.19

39.65

41.63

Extra-ordinary Items

4.82

371.75

-0.43

5.09

-3.94

Adjusted Profit After Extra-ordinary item

-134.95

-348.82

-19.75

34.55

45.57

EPS (Unit Curr.)

-63.36

11.15

-9.82

19.3

20.28

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

20.54

20.54

20.54

20.54

20.54

Public Shareholding (Number)

1,48,53,553

1,53,49,156

1,51,98,345

1,23,23,853

1,23,43,803

Public Shareholding (%)

72.33

74.73

74

60

60.09

Pledged/Encumbered - No. of Shares

44,08,131

46,66,131

50,87,560

65,81,802

70,02,802

Pledged/Encumbered - % in Total Promoters Holding

77.55

89.94

95.3

80.13

85.47

Pledged/Encumbered - % in Total Equity

21.45

22.71

24.77

32.04

34.09

Non Encumbered - No. of Shares

12,75,252

5,21,649

2,51,031

16,31,281

11,90,325

Non Encumbered - % in Total Promoters Holding

22.44

10.06

4.69

19.86

14.52

Non Encumbered - % in Total Equity

6.21

2.53

1.23

7.94

5.8

PBIDTM(%)

-11.47

65.64

13.39

17.29

16.6

PBDTM(%)

-

-

-

-

-

PATM(%)

-36.43

6.54

-3.07

5.69

5.49